ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Switching PD-1 to BRAF + MEK inhibition improves recurrence-free survival in patients receiving a second course of adjuvant melanoma therapy.

Katharina Schumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.